Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11. doi: 10.1007/s00259-016-3382-9. Epub 2016 May 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 27160225 Free PMC article.
Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesions.
van Vliet EI, Hermans JJ, de Ridder MA, Teunissen JJ, Kam BL, de Krijger RR, Krenning EP, Kwekkeboom DJ. van Vliet EI, et al. Among authors: teunissen jj. J Nucl Med. 2012 Sep;53(9):1359-66. doi: 10.2967/jnumed.112.102871. Epub 2012 Jul 10. J Nucl Med. 2012. PMID: 22782312 Free article.
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate.
van Vliet EI, van Eijck CH, de Krijger RR, Nieveen van Dijkum EJ, Teunissen JJ, Kam BL, de Herder WW, Feelders RA, Bonsing BA, Brabander T, Krenning EP, Kwekkeboom DJ. van Vliet EI, et al. Among authors: teunissen jj. J Nucl Med. 2015 Nov;56(11):1647-53. doi: 10.2967/jnumed.115.158899. Epub 2015 Aug 13. J Nucl Med. 2015. PMID: 26272813 Free article.
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.
Forrer F, Krenning EP, Kooij PP, Bernard BF, Konijnenberg M, Bakker WH, Teunissen JJ, de Jong M, van Lom K, de Herder WW, Kwekkeboom DJ. Forrer F, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1138-46. doi: 10.1007/s00259-009-1072-6. Epub 2009 Feb 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19247653 Free PMC article. Clinical Trial.
Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function.
Teunissen JJ, Krenning EP, de Jong FH, de Rijke YB, Feelders RA, van Aken MO, de Herder WW, Kwekkeboom DJ. Teunissen JJ, et al. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1758-66. doi: 10.1007/s00259-009-1151-8. Epub 2009 May 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19471926 Free PMC article.
45 results